Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FV3T8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,325
Award facts
- Contract value 100% obligated
- $6,325.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,325.48 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections. The contract is a firm fixed price delivery order with an ultimate completion date of November 5, 2025, and was awarded on November 4, 2025 without a set-aside designation. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier to the Defense Logistics Agency's medical supply chain, providing pharmaceuticals and medical supplies to military and veteran healthcare systems. This delivery order for Zepbound, a diabetes and weight management medication, reflects the company's extensive portfolio of pharmaceutical deliveries to federal healthcare programs. As a child contract under the SPE2DX IDC, this award demonstrates AmerisourceBergen's ongoing capability to meet federal procurement requirements on a competitive basis across multiple therapeutic domains and medical commodities.
Quick answers
Who was awarded contract SPE2DB26FV3T8?
SPE2DB26FV3T8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FV3T8 worth?
The government has obligated $6,325 on SPE2DB26FV3T8.
Is contract SPE2DB26FV3T8 an order under another contract?
Yes. SPE2DB26FV3T8 is a delivery order under SPE2DB20D3104, an indefinite delivery contract.
Was contract SPE2DB26FV3T8 competed?
The extent of competition for SPE2DB26FV3T8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award